Sarah Boyce, CBO at Ionis Pharmaceuticals, holds 2.26K shares in Ligand Pharma (Ticker: LGND), holds 19.89K shares in Akcea Therapeutics (Ticker: AKCA), holds 8.93K shares in Ionis Pharmaceuticals (Ticker: IONS).

See the Hottest Stocks Based on Insider Trading >

Sarah Boyce
Ionis Pharmaceuticals (IONS)
CBO

Not Ranked

Sarah Boyce has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

70.15%

IONS

29.85%

LGND

A breakdown of Sarah Boyce's holdings

See the Top Stocks by Insiders

Insider Roles

Ionis Pharmaceuticals
(IONS)

CBO

Ligand Pharma
(LGND)

Director

Roles that Sarah Boyce holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Akcea Therapeutics
(AKCA)

Rating:Informative Sell

Date:Jul 17, 2019 - Jul 17, 2020

Return:+42.10%

The most profitable trade made by Sarah Boyce

See the Latest Stocks Traded by Insiders

Sarah Boyce's Trading History

IONS

Ionis Pharmaceuticals

Jan 17, 2018

CBO

Uninformative Sell

113.66K

$456.64K

AKCA

Akcea Therapeutics

Jul 17, 2019

―

Informative Sell

42.78K

$361.36K

LGND

Ligand Pharma

Jun 12, 2020

Director

Uninformative Buy

―

$194.35K

List of latest transactions for each holding click on a transaction to see Sarah Boyce's performance on stock

See All Insider Trading from Today

Sarah Boyce insider profile FAQ

What is the percentage of profitable transactions made by Sarah Boyce?

The percentage of profitable transactions made by Sarah Boyce is ―.

What is the average return per transaction made by Sarah Boyce?

The average return per transaction made by Sarah Boyce is ―.

What stocks does Sarah Boyce hold?

Sarah Boyce holds: IONS, AKCA, LGND stocks.

What was Sarah Boyce’s latest transaction?

Sarah Boyce latest transaction was an Uninformative Buy of ―.

What was Sarah Boyce's most profitable transaction?

Sarah Boyce’s most profitable transaction was an Informative Sell of AKCA stock on July 17, 2019. The return on the trade was 42.10%.

What is Sarah Boyce's role in Ionis Pharmaceuticals?

Sarah Boyce's role in Ionis Pharmaceuticals is CBO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Sarah Boyce Insider Profile

Sarah Boyce Ionis Pharmaceuticals (IONS)CBO